In chronic myeloid leukemia (CML) two of the genes, (TFAP2A and EBF2), demonstrated increased methylation in blast crisis compared to chronic phase (P < 0.05). This evidence concerns the gene TFAP2A and chronic myelogenous leukemia, BCR-ABL1 positive.